Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STRAUSS
2018-003189-15Phase 4Completed
- Sponsor
- UZ Leuven
- Start
- Sep 2018
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, open-label trial of ustekinumab and vedolizumab in psoriasiform dermatitis and inflammatory bowel disease (IBD) (2 arms), sponsored by UZ Leuven. Started Sep 2018; status: completed.
02
Drugs
ustekinumabvedolizumab
03
Conditions
psoriasiform dermatitisinflammatory bowel disease (IBD)
Beyond the preview
Go deeper on 2018-003189-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-003189-15.